Seth Seegobin - Concepedia

Author

Seth Seegobin

King's College London

Also Known As

Quing Zhu, S Seegobin, S. Seegobin, S.D. Seegobin, Seth D Seegobin, Seth D. Seegobin, Seth Seegobin, Zhi Hong

Publications

Citations

H-Index

Concepts

All Affiliations

King's College London Guy's Hospital Cornell University King's College Hospital University of Leeds

About

Seth Seegobin is an author at King's College London specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	1.4K
2	Health Sciences	2	2	1.1K
3	Engineering	1	1	13
4	Public Health	1	1	67
5	Social Sciences	1	1	159

Seth Seegobin

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study Javier Cortés, Joyce O’Shaughnessy, David Loesch, The Lancet Metastatic Breast CancerOncologyBreast OncologyCancer ManagementClinical Trials	2011	1.1K
Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial Ruth Cooper, Emma Williams, Seth Seegobin, European Neuropsychopharmacology Cannabis UseSubstance AbuseNeuropsychologyPsychoactive DrugPsychiatry	2017	159
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa Sophie Glatt, Gregor B. E. Jemec, Seth Forman, JAMA Dermatology	2021	158
Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02 Christos Tziotzios, Christos Petridis, Nick Dand, Nature Communications	2019	117
ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial Seth Seegobin, Margaret HY, Chanaka Dahanayake, Arthritis Research & Therapy	2014	103
Predicting the Risk of Rheumatoid Arthritis and Its Age of Onset through Modelling Genetic Risk Variants with Smoking Ian C. Scott, Seth Seegobin, Sophia Steer, PLoS Genetics Genome-wide Association StudyRheumatologyTobacco ControlDisease SusceptibilityRheumatoid Disorder	2013	67
Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer Hyman B. Muss, Javier Cortés, Linda T. Vahdat, The Oncologist	2014	51
A phase III study (EMBRACE) of eribulin mesylate versus treatment of physician's choice in patients with locally recurrent or metastatic breast cancer previously treated with an anthracycline and a taxane. Chris Twelves, Danuta Z. Loesch, Joanne L. Blum, Journal of Clinical Oncology Cra1004^ BackgroundMetastatic Breast CancerBreast OncologyCancer TherapeuticsHealth Sciences	2010	40
LB5. PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-exposure Prophylaxis of COVID-19 in Adults Myron J. Levin, Andrew Ustianowski, Stéphane De Wit, Open Forum Infectious Diseases ImmunodeficienciesImmunologyImmunodominanceCovid-19 EpidemiologyAntiviral Drug	2021	34
Validation of the standardised assessment of personality - abbreviated scale in a general population sample Marcella Fok, Seth Seegobin, Souci Frissa, Personality and Mental Health	2015	33

Page 1